Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Among authors: de la rochefordiere a. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.
Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C, Sheffer M, Tsafrir D, Stransky N, Tsafrir I, Peter M, de Crémoux P, de La Rochefordière A, Salmon R, Dorval T, Thiery JP, Couturier J, Radvanyi F, Domany E, Sastre-Garau X. Rosty C, et al. Among authors: de la rochefordiere a, de cremoux p. Oncogene. 2005 Oct 27;24(47):7094-104. doi: 10.1038/sj.onc.1208854. Oncogene. 2005. PMID: 16007141
Quality of life in a randomized control trial? Comments concerning MA 17.
This P, de la Rochefordière A, Bredart A, Asselain B, Poinsot R, Dolbeault S, Sigal-Zafrani B. This P, et al. Among authors: de la rochefordiere a. J Clin Oncol. 2006 Aug 20;24(24):4038; author reply 4038-9. doi: 10.1200/JCO.2005.05.1987. J Clin Oncol. 2006. PMID: 16921063 No abstract available.
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordière A, Vincent-Salomon A, Salmon R, Campana F, Kirova YM, Dendale R, Fourquet A. Bollet MA, et al. Among authors: de la rochefordiere a. Radiother Oncol. 2007 Mar;82(3):272-80. doi: 10.1016/j.radonc.2007.01.001. Epub 2007 Feb 6. Radiother Oncol. 2007. PMID: 17287037
Hormone replacement therapy after prophylactic adnexectomy.
This P, Salmon RJ, Dolbeault S, de la Rochefordière A, Sigal-Zafrani B, Stoppa-Lyonnet D; Institut Curie Breast and Ovarian Cancer Risk Study Group. This P, et al. Among authors: de la rochefordiere a. Hered Cancer Clin Pract. 2005 Sep 15;3(4):181-2. doi: 10.1186/1897-4287-3-4-181. Hered Cancer Clin Pract. 2005. PMID: 20223046 Free PMC article.
Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study.
de la Rochefordiere A, Kirova Y, Alran S, Plancher C, Fourchotte V, Beuzeboc P, de Margerie V, Petrow P, Sastre-Garau X, Servois V, Scholl S, Cottu P, Mignot L, de Cremoux P, Salmon R. de la Rochefordiere A, et al. Among authors: de margerie v, de cremoux p. Clin Med Oncol. 2008;2:227-36. doi: 10.4137/cmo.s489. Epub 2008 Mar 27. Clin Med Oncol. 2008. PMID: 21892284 Free PMC article.
Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.
Marszalek A, Alran S, Scholl S, Fourchotte V, Plancher C, Rosty C, Meyniel JP, De Margerie V, Dorval T, De La Rochefordière A, Cottu P, Petrow P, Sastre-Garrau X, Salmon RJ. Marszalek A, et al. Among authors: de margerie v, de la rochefordiere a. Int J Surg Oncol. 2010;2010:214919. doi: 10.1155/2010/214919. Epub 2010 Jul 25. Int J Surg Oncol. 2010. PMID: 22312486 Free PMC article.
69 results